The PE Ratio as of December 2024 (TTM) for Sutro Biopharma, Inc. (STRO) is -1.21

According to Sutro Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.21. This represents a change of 136.69% compared to the average of -0.51 of the last 4 quarters.

Sutro Biopharma, Inc. (STRO) Historical PE Ratio (quarterly & annually)

How has STRO PE Ratio performed in the past?

The mean historical PE Ratio of Sutro Biopharma, Inc. over the last ten years is 2.42. The current -1.21 PE Ratio has changed -5093.64% with respect to the historical average. Over the past ten years (40 quarters), STRO's PE Ratio was at its highest in in the September 2020 quarter at 5.41. The PE Ratio was at its lowest in in the June 2021 quarter at -34.84.

Sutro Biopharma, Inc. (STRO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sutro Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sutro Biopharma, Inc. (STRO) Average PE Ratio

How has STRO PE Ratio performed in the past?

The current PE Ratio of Sutro Biopharma, Inc. (STRO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sutro Biopharma, Inc. (STRO) PE Ratio vs. Peers

How is STRO’s PE Ratio compared to its peers?

Sutro Biopharma, Inc.’s PE Ratio is greater than Vaxcyte, Inc. (-21.22), greater than Larimar Therapeutics, Inc. (-3.90), greater than Syndax Pharmaceuticals, Inc. (-3.83), greater than Merus N.V. (-11.85), greater than IDEAYA Biosciences, Inc. (-12.28), greater than AnaptysBio, Inc. (-2.44), greater than MeiraGTx Holdings plc (-4.95), greater than Keros Therapeutics, Inc. (-3.40), less than Homology Medicines, Inc. (-0.01), greater than NewAmsterdam Pharma Company N.V. (-13.31), greater than Centessa Pharmaceuticals plc (-12.61), less than Opthea Limited (-1.15), less than HilleVax, Inc. (-0.61), less than Eliem Therapeutics, Inc. (0), less than Genenta Science S.p.A. (0), less than Pardes Biosciences, Inc. (-0.01), greater than Aerovate Therapeutics, Inc. (-1.36), less than Mineralys Therapeutics, Inc. (-0.87), greater than Replimune Group, Inc. (-3.92), greater than null (-4.55),

Build a custom stock screener for Sutro Biopharma, Inc. (STRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sutro Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sutro Biopharma, Inc. (STRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sutro Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.